Invention Grant
- Patent Title: Substituted imidazoquinolines
-
Application No.: US17590550Application Date: 2022-02-01
-
Publication No.: US12054485B2Publication Date: 2024-08-06
- Inventor: Christophe Henry
- Applicant: BIONTECH SE
- Applicant Address: DE Mainz
- Assignee: BIONTECH SE
- Current Assignee: BIONTECH SE
- Current Assignee Address: DE Mainz
- Agency: McDonnell Boehnen Hulbert & Berghoff LLP
- Priority: WO TEP2017072352 2017.09.06
- Main IPC: C07D471/04
- IPC: C07D471/04 ; A61P35/00
Abstract:
The invention relates to imidazoquinoline derivatives and to pharmaceutical compositions containing the imidazoquinoline derivatives. The imidazoquinoline derivatives of the invention are useful as toll-like receptor agonists, in particular agonists of TLR7, and promote induction of certain cytokines.
Public/Granted literature
- US20220227756A1 SUBSTITUTED IMIDAZOQUINOLINES Public/Granted day:2022-07-21
Information query
